María Emilia Gaillard

Title: The Innovative Contributions of Inventor María Emilia Gaillard

Introduction

María Emilia Gaillard is a notable inventor based in La Plata, Buenos Aires, Argentina. He has made significant strides in the field of vaccine development, particularly focusing on the prevention of infections. His work has the potential to impact public health positively.

Latest Patents

María Emilia Gaillard holds 1 patent for a vaccine designed to prevent infections. This innovative vaccine comprises at least outer membrane vesicles (OMVs) and various excipients and/or adjuvants. The formulation may include adjuvants such as aluminum hydroxide and immunogens like tetanus toxoid and diphtheria toxoid. The vaccine is designed to deliver between 3 to 20 µg per dose of OMVs and a specific amount of lipopolysaccharide from bacteria. This vaccine exhibits cross-activity, showcasing its potential effectiveness.

Career Highlights

Throughout his career, María Emilia Gaillard has been associated with prominent research institutions. He has worked at the National Scientific and Technical Research Council (CONICET) and the National University of La Plata. His contributions to vaccine research have been recognized within the scientific community.

Collaborations

María Emilia Gaillard has collaborated with esteemed colleagues, including Daniela Hozbor and Daniela Bottero. These partnerships have enhanced the research and development of his innovative vaccine.

Conclusion

María Emilia Gaillard's work in vaccine development represents a significant advancement in the fight against infections. His innovative approach and collaborations with other researchers highlight the importance of teamwork in scientific progress.